Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Salvador-Carulla, L.
Atienza, C.
and
Romero, C.
1999.
Manage or Perish?.
p.
359.
Knapp, Martin
2000.
Schizophrenia costs and treatment cost‐effectiveness.
Acta Psychiatrica Scandinavica,
Vol. 102,
Issue. s407,
p.
15.
Domino, Marisa E.
and
Salkever, David S.
2000.
Recent economic research on service utilization and costs: schizophrenia and substance abuse.
Current Opinion in Psychiatry,
Vol. 13,
Issue. 2,
p.
227.
Küstner, B. Moreno
González, F. Torres
and
Del Castillo, J.D. Luna
2001.
Analysis of patterns of mental health care with three different approaches (cross-sectional, longitudinal and dynamic).
Epidemiologia e Psichiatria Sociale,
Vol. 10,
Issue. 2,
p.
82.
&NA;
2002.
III The context for the use of the second-generation antipsychotic medications: opportunities and constraints.
Current Opinion in Psychiatry,
Vol. 15,
Issue. ,
p.
S17.
Chisholm, Daniel
and
Knapp, Martin
2002.
The economics of schizophrenia care in Europe: the Epsilon study.
Epidemiologia e Psichiatria Sociale,
Vol. 11,
Issue. 1,
p.
12.
Urdahl, H.
Knapp, M.
Edgell, E. T.
Ghandi, G.
and
Haro, J. M.
2003.
Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study.
Acta Psychiatrica Scandinavica,
Vol. 107,
Issue. s416,
p.
41.
Kilian, R.
Matschinger, H.
Becker, T.
and
Angermeyer, M. C.
2003.
A longitudinal analysis of the impact of social and clinical characteristics on the costs of schizophrenia treatment.
Acta Psychiatrica Scandinavica,
Vol. 107,
Issue. 5,
p.
351.
Haro, J. M.
Edgell, E. T.
Jones, P. B.
Alonso, J.
Gavart, S.
Gregor, K. J.
Wright, P.
and
Knapp, M.
2003.
The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.
Acta Psychiatrica Scandinavica,
Vol. 107,
Issue. 3,
p.
222.
Bobes, Julio
Cañas, Fernando
Rejas, Javier
and
Mackell, Joan
2004.
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 28,
Issue. 8,
p.
1287.
Alptekin, Köksal
Akdede, Berna Binnur
Akvardar, Yildiz
çelikgün, Songül
Dilşen, N. Sinem
Durak, Güliz
Türk, Ayşe
and
Fidaner, Hüray
2004.
Quality of Life Assessment in Turkish Patients with Schizophrenia and Their Relatives.
Psychological Reports,
Vol. 95,
Issue. 1,
p.
197.
SOA, K.
2004.
PERSISTENT NEUROPSYCHOLOGICAL PROBLEMS AFTER 7 YEARS OF ABSTINENCE FROM RECREATIONAL ECSTASY (MDMA): A CASE STUDY.
Psychological Reports,
Vol. 95,
Issue. 5,
p.
192.
Kilian, Reinhold
and
Becker, Thomas
2005.
Impact of antipsychotic medication on the cost of schizophrenia.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 5,
Issue. 1,
p.
39.
Cabasés, Juan M
Sánchez, Eduardo
Vázquez-Polo, Francisco J
Negrín, Miguel A
and
Domínguez, Emilio J
2005.
Self-perceived health status of schizophrenic patients in Spain: analysis of geographic differences.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 5,
Issue. 5,
p.
531.
Grover, Sandeep
Avasthi, Ajit
Chakrabarti, Subho
and
Kulhara, Paramanand
2005.
Overview and emerging trends.
Indian Journal of Psychiatry,
Vol. 47,
Issue. 4,
p.
205.
Salvador-Carulla, Luis
Tibaldi, Giuseppe
Johnson, Sonia
Scala, Elena
Romero, Cristina
and
Munizza, Carmine
2005.
Patterns of mental health service utilisation in Italy and Spain.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 40,
Issue. 2,
p.
149.
Oliva-Moreno, Juan
López-Bastida, Julio
Osuna-Guerrero, Rubén
Montejo-González, Angel Luis
and
Duque-González, Beatriz
2006.
The costs of schizophrenia in Spain.
The European Journal of Health Economics,
Vol. 7,
Issue. 3,
p.
179.
Haro, Josep Maria
Kontodimas, Stathis
Negrin, Miguel Angel
Ratcliffe, Mark
Suarez, David
and
Windmeijer, Frank
2006.
Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes Studies.
Applied Health Economics and Health Policy,
Vol. 5,
Issue. 1,
p.
11.
Gutierrez‐Recacha, P.
Chisholm, D.
Haro, J. M.
Salvador‐Carulla, L.
and
Ayuso‐Mateos, J. L.
2006.
Cost‐effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain.
Acta Psychiatrica Scandinavica,
Vol. 114,
Issue. s432,
p.
29.
Bernardo, Miguel
Ram??n Azanza, Jose
Rubio-Terr??s, Carlos
and
Rejas, Javier
2006.
Cost-Effectiveness Analysis of Schizophrenia Relapse Prevention.
Clinical Drug Investigation,
Vol. 26,
Issue. 8,
p.
447.
eLetters
No eLetters have been published for this article.